PCMG Sustainability Action Group
The PCMG Sustainability Action Group is committed to driving positive change in the pharmaceutical and clinical outsourcing sectors by embedding sustainability into everyday business practices. Guided by key principles of resilience, well-being, and global responsibility, the group brings together industry professionals to translate sustainability goals into meaningful action. By fostering collaboration and sharing best practices, the group seeks to reduce environmental impact, support resource-efficient clinical development, and help organisations—especially small biotech companies—establish feasible sustainability frameworks.
To achieve its mission, the PCMG Sustainability Action Group has initiated several practical tools and resources. These include a Start-Up Package to help companies integrate sustainability into their operations, contract wording recommendations to reinforce commitments across partnerships, and a sustainability questionnaire designed to facilitate dialogue with stakeholders. Members can access these through the resource page.
Kits for Life in Focus: Exploring Sourcing and Operational Implications
September 2025
Sustainability Action Group Insights Session 1
March 2025
PCMG Sustainability Action Group Members
Thierry Escudier Pistoia Alliance
Thierry Escudier is a senior leader in Clinical Operations with a strong focus on digital innovation and patient centricity. A PCMG member since 2004 and an independent consultant since 2021, he serves as a Strategic Leader for the Pistoia Alliance, a global non-profit dedicated to advancing innovation in life sciences and healthcare R&D. Thierry leads the Pistoia Alliance project on the Carbon Footprint of Clinical Trials, a collaborative effort involving 10 pharmaceutical companies and six CROs to develop a standardized approach for evaluating the environmental impact of decentralized clinical trials (DCTs).
Stuart McGuire Veramed
Stuart McGuire has over 20 years of pharmaceutical experience and leads Veramed’s growth as a premier biometrics CRO partner. As Veramed’s Environmental Ambassador, he drives the company’s B Corp certification and leads the cross-company Environment ‘Hive’. Additionally, Stuart is an active member of the PCMG Sustainability Action Group, where he supports sustainability initiatives and contributes to the PCMG Annual Assembly.
Inga Nachreiner argenx BV
Inga Nachreiner is a senior Clinical Sourcing Manager at argenx BV, specializing in innovative clinical study outsourcing to enhance patient centricity and ensure fast, high-quality delivery. A PCMG member since 2008 and a committee member since 2023, she holds a PhD in Molecular Biology and Pharmaceutical Product Development. With 15 years of experience in Clinical Development and Procurement across Global Pharma and BioTech, she is also a dedicated mother of three, navigating the challenges of a changing climate.
Jo Humphrey Bayer
I’m a Senior Clinical Contracts Specialist at Reckitt responsible for ensuring compliance in our clinical studies through contract drafting, negotiation, consultation, and data protection oversight. My role is underpinned by a legal background and a certification as a Data Protection Officer, and I bring over 15 years of experience in the research industry.
I’m passionate about challenging the status quo in clinical outsourcing and shaping more agile, transparent, and collaborative approaches to research partnerships. I believe we can move beyond “business as usual” to create smarter models that truly support innovation. As a member of the steering group, I look forward to contributing my cross-functional experience and somewhat unique insight to help drive meaningful change in the clinical trials landscape.
Sandra Johnson
Sandra has over 20 years experience in life science project management, outsourcing and sustainability. She is a member of the PCMG and one of the newer members of the Sustainability Action Group. Sandra is passionate about the environment and particularly enjoys aligning teams to ensure optimal impact across clinical trial ecosystems in low and middle income countries.
